
Suphyllin 84.7mg/25.3mg Injection
Marketer
Paksons Pharmaceuticals Pvt Ltd
Salt Composition
Etofylline (84.7mg) + Theophylline (25.3mg)
Overview Suphyllin 84.7mg/25.3mg Injection
Aminophylline injection (84.7mg/25.3mg) is indicated for managing asthma and chronic obstructive pulmonary disease (COPD), a lung condition characterized by airflow obstruction. This medication facilitates bronchodilation, easing respiratory effort. Administration is solely by a physician or qualified nurse, with dosage tailored to individual patient response and disease severity. Continued use, as directed by your doctor, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Comprehensive disclosure of all concurrent medications is essential, as potential drug interactions exist. Commonly reported adverse effects include nausea, vomiting, dyspepsia, headache, and agitation; most are transient and self-limiting. However, any concerning side effects warrant immediate medical attention. Prior to commencing treatment, patients should inform their physician of any pre-existing cardiac, renal, or hepatic conditions to ensure appropriate dosage selection. Pregnancy, pregnancy planning, or breastfeeding should also be disclosed to your doctor.
Primary Ingredients of Suphyllin 84.7mg/25.3mg Injection
No text provided to rephrase.
Uses of Suphyllin 84.7mg/25.3mg Injection
Managing Chronic Obstructive Pulmonary Disease (COPD)
Major Benefits of Suphyllin 84.7mg/25.3mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Suphyllin 84.7mg/25.3mg Injection:
- Nausea
- Vomiting
- Headache
- Restlessness
How to use Suphyllin 84.7mg/25.3mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Suphyllin 84.7mg/25.3mg Injection works:
Etofylline and theophylline, combined in Suphyllin 84.7mg/25.3mg Injection, act as bronchodilators. By relaxing airway muscles, this medication expands the airways, thereby facilitating respiration.
SAFETY ADVICE
AlcoholUNSAFE
Combining Suphyllin 84.7mg/25.3mg Injection and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Suphyllin 84.7mg/25.3mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Suphyllin 84.7mg/25.3mg is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant. A precautionary measure to further minimize infant exposure is to temporarily abstain from breastfeeding for two to four hours following administration.
DrivingCONSULT YOUR DOCTOR
The effect of Suphyllin 84.7mg/25.3mg Injection on driving ability is undetermined. Refrain from driving if you encounter symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Suphyllin 84.7mg/25.3mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Suphyllin 84.7mg/25.3mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification for Suphyllin 84.7mg/25.3mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Suphyllin 84.7mg/25.3mg Injection :
Should you forget a scheduled dose of Suphyllin 84.7mg/25.3mg Injection, seek advice from your physician.
Facts to Know About Suphyllin 84.7mg/25.3mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Breathing |
